论文部分内容阅读
本文报告５８例伊索显２８０与欧乃派克３００脑血管造影对比随机双盲临床试验，其中３０例应用伊索显２８０，２８例应用欧乃派克３００实验。实验证明大多数调查者认为两种造影剂的质量好（伊索显占９２．６％，欧乃派克占９４．３％）。在检查期间，两组的副反应显示率相似（ｐ＞０．０５，无显著差异）。检查后，在大组中伊索显２８０总的副反应率低于欧乃派克３００（ｐ＜０．０５，有显著差异）检查后，在大组中伊索显２８０头痛的发生率明显低于欧乃派克３００（ｐ＜０．０５，有极显著差异）。伊索显２８０副反应的病例比欧乃派克副反应的病例少，程度轻，因此伊索显２８０对脑血管造影是一种有效、耐受性好和安全的造影剂。
This article reports 58 cases of Isopigment 280 and Omnipack 300 cerebral angiography compared to randomized double-blind clinical trials, of which 30 cases of the application of Isopia 280, 28 cases of the application of the Omni Park 300 experiments. Experiments show that most investigators believe the two contrast agents are of good quality (Aesop’s 92.6% and Unipis 94.3%). Side effects during the study showed similar rates of side effects (p> 0.05, no significant difference). After the test, the overall incidence of Isopia 280 in the large cohort was lower than that of the Unipharmic 300 (p <0.05, significant difference) after the test, the incidence of obsidian 280 headache in the large cohort was significantly lower At Omniplex 300 (p <0.05, significant difference). Aesoplan 280 has fewer and fewer side effects than the other side effects of Omnipaque. Therefore, Isopigin 280 is an effective, well tolerated and safe contrast agent for cerebral angiography.